Cargando…
Dysregulation of MS risk genes and pathways at distinct stages of disease
OBJECTIVE: To perform systematic transcriptomic analysis of multiple sclerosis (MS) risk genes in peripheral blood mononuclear cells (PBMCs) of subjects with distinct MS stages and describe the pathways characterized by dysregulated gene expressions. METHODS: We monitored gene expression levels in P...
Autores principales: | Srinivasan, Sundararajan, Di Dario, Marco, Russo, Alessandra, Menon, Ramesh, Brini, Elena, Romeo, Marzia, Sangalli, Francesca, Costa, Gloria Dalla, Rodegher, Mariaemma, Radaelli, Marta, Moiola, Lucia, Cantarella, Daniela, Medico, Enzo, Martino, Gianvito, Furlan, Roberto, Martinelli, Vittorio, Comi, Giancarlo, Farina, Cinthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356498/ https://www.ncbi.nlm.nih.gov/pubmed/28349074 http://dx.doi.org/10.1212/NXI.0000000000000337 |
Ejemplares similares
-
Myeloid cells as target of fingolimod action in multiple sclerosis
por: Di Dario, Marco, et al.
Publicado: (2015) -
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
por: Srinivasan, Sundararajan, et al.
Publicado: (2017) -
Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
por: Srinivasan, Sundararajan, et al.
Publicado: (2018) -
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective
por: Messina, Maria Josè, et al.
Publicado: (2015) -
Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning
por: Acquaviva, Massimo, et al.
Publicado: (2020)